血液分析儀市場

全球血液分析儀市場規模將從 2023 年的 40 億美元增長到 2028 年的 53 億美元，2023 年至 2028 年的預測期內復合年增長率為 5.7%。預計將會增長。

試劑和耗材行業預計到 2028 年將增長至 36 億美元，複合年增長率為 6.0%，從 2023 年的 27 億美元增長。 設備行業預計將從 2023 年的 10 億美元增長到 2028 年的 13 億美元，複合年增長率為 4.8%。

在本報告中，我們研究了全球血液分析儀市場，並提供了市場概況、市場影響因素和市場機會分析、專利趨勢、市場規模趨勢和預測、各個細分市場和地區的詳細分析、臨床測試總結分析、新興技術趨勢、競爭格局、主要公司簡介等等。

內容

第一章簡介

第 2 章摘要要點

第三章市場和技術背景

• 血液分析儀的歷史
• 血液分析儀概述
• 流式細胞術
• 電阻抗
• 激光衍射
• 主要血液分析儀
• 血液檢測參數
• 血液分析儀的使用
• 貧血
• 血癌
• 感染
• 自身免疫性疾病、遺傳性血液病
• 其他

第四章市場動態

• 市場動態
• 市場驅動因素
• 市場製約因素
• 市場機會

第五章行業概述

• 血液分析儀價值鏈
• 研發
• 製造業
• 分銷和銷售
• 最終用戶服務與支持
• 監管狀況
• 原裝試劑與第三方試劑對比
• 投資回報率

第 6 章 COVID-19 的影響

第七章臨床試驗分析

• 臨床試驗分析
• 臨床試驗分析：按研究類型
• 臨床試驗分析：按狀態分類
• 臨床試驗分析：按階段
• 臨床試驗分析：按地區

第八章專利審查

第 9 章市場中的新興技術

• 新興技術
• 商業化
• 工作流程
• 分析
• 臨床信息管理
• 血液學趨勢
• 數字形態學
• 人工智能
• 即時檢測

第 10 章市場細分：按產品/服務

• 市場概覽
• 市場份額/預測
• 試劑和耗材
• 工具
• 5 部分和 6 部分血液分析儀
• 三聯血細胞分析儀
• 用於即時檢測的血液分析儀
• 半自動血細胞分析儀
• 服務

第 11 章市場細分：按最終用戶劃分

• 市場概覽
• 市場份額/預測
• 診斷中心
• 醫院和診所
• 研究所
• 其他

第 12 章市場細分：按地區

• 北美
• 亞太地區
• 歐洲
• 其他地區

第13章競爭格局

• 市場份額分析
• PESTEL 分析
• 波特五力分析
• 主要公司的近期趨勢

第14章公司簡介

• ABBOTT
• BIO-RAD LABORATORIES, INC.
• BOULE DIAGNOSTICS AB
• DANAHER
• DIATRON
• EKF DIAGNOSTICS HOLDINGS PLC
• HORIBA LTD.
• NIHON KOHDEN CORP.
• NORMA INSTRUMENTS
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
• SIEMENS HEALTHINEERS AG
• SYSMEX CORP.
• TRANSASIA BIO-MEDICALS
• TRIVITRON HEALTHCARE
• WIENER LABORATORIOS SAIC

Highlights:

The global market for hematology analyzers is estimated to increase from $4.0 billion in 2023 to reach $5.3 billion by 2028, at a compound annual growth rate (CAGR) of 5.7% from 2023 through 2028.

The global market for hematology analyzers for reagents and consumables segment is estimated to increase from $2.7 billion in 2023 to reach $3.6 billion by 2028, at a CAGR of 6.0% from 2023 through 2028.

The global market for hematology analyzers for instruments is estimated to increase from $1.0 billion in 2023 to reach $1.3 billion by 2028, at a CAGR of 4.8% from 2023 through 2028.

Report Scope:

The current report provides detailed exposure to the hematology analyzer market. This report highlights the current and future market potential of hematology analyzers, along with a detailed analysis of the drivers and challenges in the market. The report also covers market projections through 2028 and market rank for key players. It covers the competitive environment, regulatory scenario and outlines market share based on product/service and end user. Products/services include Instruments, Reagents and Consumables and Services. The market end users are hospitals and clinics, diagnostic centers, research institutes and other end users. This report includes company profiles of key players with detailed information on business segments, financials, product portfolios and recent developments. The report examines the impact of the COVID-19 pandemic on this market.

By geographical region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S. and Canada; Europe includes Germany, the UK, Italy, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as historical years, 2022 as the base year and forecasts have been made through 2028.

Report Includes:

• 19 data tables and 45 additional tables
• An overview of global market outlook for hematology analyzers
• Analyses of global market trends, with data from 2020-2023 and projections of compound annual growth rates (CAGRs) through 2028
• Identification of market trends, issues and forecast impacting the global hematology analyzers market and quantification of the market based on product/service, end user, and region
• Discussion on market drivers such as growing incidence of blood disorders, increased preference for automated hematology instruments, and technological advancements in hematology analyzers
• Discussion on recent advancements and innovations available in the market
• Comprehensive company profiles of key players in the market, including Abbott, Boule Diagnostics AB, EKF Diagnostics Holdings Plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corp., and Nihon Kohden Corp.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Information Sources
• Methodology
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

• Highlights of the Market for Hematology Analyzers

Chapter 3 Market and Technology Background

• History of the Hematology Analyzer
• Introduction to the Hematology Analyzer
• Flow Cytometry
• Electrical Impedance
• Laser Diffraction
• Selection of Hematology Analyzers
• Blood Test Parameters
• Hematology Analyzer Applications
• Anemia
• Blood Cancer
• Infection
• Autoimmune and Genetic Blood Diseases
• Others

Chapter 4 Market Dynamics

• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities

Chapter 5 Industry Overview

• Value Chain of Hematology Analyzers
• Research and Development
• Manufacturing
• Distribution and Sales
• Service and Support to End Users
• Regulatory Landscape
• Regulatory Landscape, North America
• Regulatory Landscape, Europe
• Regulatory Landscape, Asia-Pacific
• Regulatory Landscape, Rest of the World
• Original Reagents vs. Third-Party Hematology Reagents
• Return on Investment

Chapter 6 Impact of the COVID-19 Pandemic

• Impact of COVID-19 on the Hematology Analyzer Market

Chapter 7 Clinical Trial Analysis

• Clinical Trial Analysis
• Clinical Trial Analysis, by Type of Study
• Clinical Trial Analysis, by Status
• Clinical Trials Analysis, by Phase
• Clinical Trial Analysis, by Region

Chapter 8 Patent Review

• Patents, by Year
• By Top Applicant
• By Top Owner
• By Jurisdiction

Chapter 9 Emerging Technologies in the Market

• Emerging Technology, Hematology Analyzer Market
• Commercialization
• Workflow
• Analysis
• Clinical Information Management
• Trends in Hematology
• Digital Morphology
• Artificial Intelligence (AI)
• Point-of-Care-Testing

Chapter 10 Market Breakdown by Product/Service

• Market Overview
• Market Share and Forecast
• Reagents and Consumables
• Instruments
• 5- and 6-part Hematology Analyzers
• 3-part Hematology Analyzers
• Point-of-care Testing Hematology Analyzers
• Semi-automatic Hematology Analyzers
• Services

Chapter 11 Market Breakdown by End User

• Market Overview
• Market Share and Forecast
• Diagnostic Centers
• Hospitals and Clinics
• Research Institutions
• Other End Users

Chapter 12 Market Breakdown by Region

• Global Market for Hematology Analyzer by Region
• North America
• U.S.
• Canada
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Europe
• Germany
• UK
• Italy
• France
• Rest of Europe
• Rest of the World

Chapter 13 Competitive Landscape

• Market Share Analysis
• Sysmex Corporation
• Danaher
• PESTEL Analysis
• Politics
• Economy
• Society
• Technology
• Law
• Environment
• Porter's Five Forces Analysis
• Bargaining Power of Supplier: Medium
• Bargaining Power of Buyers: Medium
• The Threat of Substitutes: Low
• The Threat of New Entrants: Moderate
• The Intensity of Competitive Rivalry: High
• Recent Developments of Key Market Players

Chapter 14 Company Profiles

• ABBOTT
• BIO-RAD LABORATORIES, INC.
• BOULE DIAGNOSTICS AB
• DANAHER
• DIATRON
• EKF DIAGNOSTICS HOLDINGS PLC
• HORIBA LTD.
• NIHON KOHDEN CORP.
• NORMA INSTRUMENTS
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
• SIEMENS HEALTHINEERS AG
• SYSMEX CORP.
• TRANSASIA BIO-MEDICALS
• TRIVITRON HEALTHCARE
• WIENER LABORATORIOS SAIC

List of Tables

• Summary Table A : Global Market for Hematology Analyzers, by Product/Service, Through 2028
• Summary Table B : Global Market for Hematology Analyzers, by Region, Through 2028
• Table 1 : Hematology Analyzers, by Type of Facility
• Table 2 : Blood Component, Normal Range
• Table 3 : Device Classes in the U.S., Risk Level and Controls
• Table 4 : Class I and II Exempt Devices
• Table 5 : Asia-Pacific: Regulatory Landscape
• Table 6 : Table 6 RoW: Regulatory Landscape
• Table 7 : Third-Party vs. OEM Controls
• Table 8 : Decline in Visits During COVID-19 Pandemic, by Provider Specialty
• Table 9 : Clinical Trials in Hematology, by Type of Study, April 2023
• Table 10 : Clinical Trials in Hematology, by Status, April 2023
• Table 11 : Clinical Trials in Hematology, by Phase, April 2023
• Table 12 : Clinical Trials in Hematology, by Region, April 2023
• Table 13 : Number of Patents, by Top Applicant, 2018-2022
• Table 14 : Number of Patents, by Top Owner, 2018-2020
• Table 15 : Number of Patents, by Jurisdiction, 2018-2022
• Table 16 : Global Market for Hematology Analyzers, by Product/Service, Through 2028
• Table 17 : Global Market for Reagents and Consumables, by Region, Through 2028
• Table 18 : Global Market for Instruments, by Region, Through 2028
• Table 19 : Global Market for Instruments, by Product, Through 2028
• Table 20 : Global Market for 5- and 6-part Hematology Analyzers, by Region, Through 2028
• Table 21 : Common Parameters Measured, by 3-part Hematology Analyzer
• Table 22 : Global Market for 3-part Hematology Analyzers, by Region, Through 2028
• Table 23 : Point-of-Care Hb Testing Analyzers
• Table 24 : Global Market for Point-of-Care Testing Hematology Analyzers, by Region, Through 2028
• Table 25 : Global Market for Semi-automatic Hematology Analyzers, by Region, Through 2028
• Table 26 : Global Market for Services, by Region, Through 2028
• Table 27 : Global Market for Hematology Analyzers, by End User, Through 2028
• Table 28 : Global Market for Diagnostic Centers, by Region, Through 2028
• Table 29 : Hospitals, by Country
• Table 30 : Global Market for Hospitals and Clinics, by Region, Through 2028
• Table 31 : Global Market for Research Institutions, by Region, Through 2028
• Table 32 : Global Market for Other End Users, by Region, Through 2028
• Table 33 : Global Market for Hematology Analyzers, by Region, Through 2028
• Table 34 : North American Market for Hematology Analyzers, by Country, Through 2028
• Table 35 : Asia-Pacific: Blood Cancer, Incidence, Mortality and Prevalence, 2020
• Table 36 : Asia-Pacific Market for Hematology Analyzers, by Country, Through 2028
• Table 37 : European Market for Hematology Analyzers, by Country, Through 2028
• Table 38 : Health Expenditure, by Country, 2021
• Table 39 : Recent Developments, 2020-2022
• Table 40 : Abbott: Product Portfolio
• Table 41 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 42 : Boule Diagnostics AB: Product Portfolio
• Table 43 : Boule Diagnostics AB: Key Developments, 2021-2022
• Table 44 : Danaher: Product Portfolio
• Table 45 : Danaher: Key Developments, 2020-2022
• Table 46 : Diatron: Product Portfolio
• Table 47 : Diatron: Key Developments, 2022
• Table 48 : EKF Diagnostics Holdings Plc: Product Portfolio
• Table 49 : EKF Diagnostics Holdings Plc: Key Developments, 2022
• Table 50 : Horiba Ltd.: Product Portfolio
• Table 51 : Horiba Ltd.: Key Developments, 2020-2022
• Table 52 : Nihon Kohden Corp.: Product Portfolio
• Table 53 : Nihon Kohden Corp.: Key Developments, 2020-2022
• Table 54 : Norma Instruments: Product Portfolio
• Table 55 : Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Product Portfolio
• Table 56 : Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Key Developments, 2022
• Table 57 : Siemens Healthineers AG: Product Portfolio
• Table 58 : Sysmex Corp.: Product Portfolio
• Table 59 : Sysmex Corp.: Key Developments, 2021 and 2022
• Table 60 : Transasia Bio-Medicals: Product Portfolio
• Table 61 : Trivitron Healthcare: Product Portfolio
• Table 62 : Wiener Laboratorios SAIC: Product Portfolio

List of Figures

• Summary Figure A : Global Market for Hematology Analyzers, by Product/Service, 2020-2028
• Summary Figure B : Global Market for Hematology Analyzers, by Region, 2020-2028
• Figure 1 : Factors for Selection of Hematology Analyzers
• Figure 2 : Parameters Measured, by Hematology Analyzer
• Figure 3 : Hematology Analyzers: Applications
• Figure 4 : Hematology Analyzer: Market Dynamics
• Figure 5 : Global: Number of Non-Pregnant Women (15-49 Years) with Anemia
• Figure 6 : Global: Number of Children (6-59 Months) with Anemia
• Figure 7 : Value Chain Analysis
• Figure 8 : Medical Device Marketing Process, U.S.
• Figure 9 : Hematology Analyzers: ROI Factors
• Figure 10 : COVID-19 Impact on Key Companies
• Figure 11 : Patents Granted, by Year, 2018-2022
• Figure 12 : Patent Share, by Top Applicant, 2018-2022
• Figure 13 : Patents Share, by Top Owner, 2018-2022
• Figure 14 : Global Market Shares of Hematology Analyzers, by Product/Service, 2022
• Figure 15 : Global Market for Reagents and Consumables, by Region, 2020-2028
• Figure 16 : Global Market for Instruments, by Region, 2020-2028
• Figure 17 : Global Market Shares of Instruments, by Product, 2022
• Figure 18 : Global Market for 5- and 6-part Hematology Analyzers, by Region, 2020-2028
• Figure 19 : Global Market for 3-part Hematology Analyzers, by Region, 2020-2028
• Figure 20 : Global Market for Point-of-Care Testing Hematology Analyzers, by Region, 2020-2028
• Figure 21 : Global Market for Semi-automatic Hematology Analyzers, by Region, 2020-2028
• Figure 22 : Global Market for Services, by Region, 2020-2028
• Figure 23 : Global Market Shares of Hematology Analyzers, by End User, 2022
• Figure 24 : Global Market for Diagnostic Centers, by Region, 2020-2028
• Figure 25 : Global Market for Hospitals and Clinics, by Region, 2020-2028
• Figure 26 : Global Market for Research Institutions, by Region, 2020-2028
• Figure 27 : Global Market for Other End Users, by Region, 2020-2028
• Figure 28 : Global Market Shares of Hematology Analyzers, by Region, 2022
• Figure 29 : North America: Anemia Prevalence, 2017-2019
• Figure 30 : North American Market Shares of Hematology Analyzers, by Country, 2022
• Figure 31 : U.S.: Blood Cancer Incidence, by Type, 2021
• Figure 32 : U.S. Market for Hematology Analyzers, 2020-2028
• Figure 33 : Canadian Market for Hematology Analyzers, 2020-2028
• Figure 34 : Asia-Pacific Market Shares of Hematology Analyzers, by Country, 2022
• Figure 35 : Chinese Market for Hematology Analyzers, 2020-2028
• Figure 36 : Indian Market for Hematology Analyzers, 2020-2028
• Figure 37 : Japanese Market for Hematology Analyzers, 2020-2028
• Figure 38 : Rest of Asia-Pacific Market for Hematology Analyzers, 2020-2028
• Figure 39 : European Market Shares of Hematology Analyzers, by Country, 2022
• Figure 40 : German Market for Hematology Analyzers, 2020-2028
• Figure 41 : U.K. Market for Hematology Analyzers, 2020-2028
• Figure 42 : Italian Market for Hematology Analyzers, 2020-2028
• Figure 43 : French Market for Hematology Analyzers, 2020-2028
• Figure 44 : Rest of the European Market for Hematology Analyzers, 2020-2028
• Figure 45 : Rest of the World Market for Hematology Analyzers, 2020-2028
• Figure 46 : Global Hematology Analyzer Company Market Shares, 2022
• Figure 47 : Hematology Analyzers: PESTEL Analysis
• Figure 48 : Number of Hematology Research Papers Published at PubMed, 2018-2022
• Figure 49 : Abbott: Diagnostic Revenue, 2020-2022
• Figure 50 : Abbott: Diagnostics Segment Market Share, by Business Segment, 2022
• Figure 51 : Abbott: Diagnostics Segment Market Share, by Region, 2021
• Figure 52 : Bio-Rad Laboratories Inc.: Total Revenue, 2020-2022
• Figure 53 : Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2022
• Figure 54 : Bio-Rad Laboratories Inc.: Market Share, by Region, 2022
• Figure 55 : Boule Diagnostics AB: Total Revenue, 2020-2022
• Figure 56 : Boule Diagnostics AB: Market Share, by Business Segment, 2022
• Figure 57 : Boule Diagnostics AB: Market Share, by Region, 2022
• Figure 58 : Danaher: Diagnostics Segment Revenue, 2020-2022
• Figure 59 : Danaher: Market Share, by Business Segment, 2022
• Figure 60 : Danaher: Diagnostics Segment Market Share, by Region, 2022
• Figure 61 : EKF Diagnostics Holdings Plc: Total Revenue, 2020-2022
• Figure 62 : EKF Diagnostics Holdings Plc: Market Share, by Business Segment, 2022
• Figure 63 : EKF Diagnostics Holdings Plc: Market Share, Diagnostics Segment, by Region, 2022
• Figure 64 : Horiba, Ltd.: Medical/Diagnostic Revenue, 2020-2022
• Figure 65 : Horiba Ltd.: Market Share, by Business Segment, 2022
• Figure 66 : Horiba Ltd.: Medical- Diagnostic Segment Market Share, by Region, 2022
• Figure 67 : Nihon Kohden Corp.: Total Revenue, 2019-2021
• Figure 68 : Nihon Kohden Corp.: Market Share, by Business Segment, 2021
• Figure 69 : Nihon Kohden Corp.: Market Share, by Region, 2021
• Figure 70 : Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Revenue, 2019-2021
• Figure 71 : Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Market Share, by Business Segment, 2021
• Figure 72 : Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Market Share, by Region, 2021
• Figure 73 : Siemens Healthineers AG: Diagnostics Revenue, 2020-2022
• Figure 74 : Siemens Healthineers AG: Market Share, by Business Segment, 2022
• Figure 75 : Siemens Healthineers AG: Market Share, by Region, 2022
• Figure 76 : Sysmex Corp.: Hematology Revenue, 2019-2021
• Figure 77 : Sysmex Corp.: Market Share, by Business Segment, 2021
• Figure 78 : Sysmex Corp.: Market Share, by Region, 2021